A possible explanation is that dual TLR3/CD40 stimulation facilitated DCs to generate tumor-specific Th1 cells62 that enhanced effector function of tumor-specific CD8+ T cells49 and IFN-γ production in the TME35,60. The gene discussed is IFNG; the disease is neoplasm.